Methylated heparin compound as well as preparation and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SUZHOU RONGXI BIOTECH CO LTD
- Publication Date
- 2020-12-15
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of biomedicine, in particular to heparin drugs and their preparation. Background technique
[0002] At present, heparin drugs are the most widely used anticoagulant and antithrombotic drugs in clinical practice, and are included in domestic and foreign pharmacopoeias, including Chinese Pharmacopoeia (ChP 2015), European Pharmacopoeia (EP 9.0), and United States Pharmacopoeia (USP 40). Heparin is a sulfated glycosaminoglycan. Its structure is a linear chain structure formed by alternating 1→4 glycosidic bonds between L-iduronic acid or D-glucuronic acid and D-glucosamine sulfate. The structural formula is as follows:
[0003]
[0004] The molecular weight of natural heparin is 3000Da-30000Da, and the average molecular weight is about 15000Da.
[0005] Since sulfated glycosaminoglycans are highly hydrophilic and highly polar substances, the injection form of heparin is the main dosage form. However, the in...